The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,636.00
Bid: 1,638.00
Ask: 1,639.00
Change: -15.00 (-0.91%)
Spread: 1.00 (0.061%)
Open: 1,656.50
High: 1,661.50
Low: 1,635.50
Prev. Close: 1,651.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

14 Apr 2014 05:24

PRESS: GSK Faces Bribery Probe In Poland - The BBC

LONDON (Alliance News) - UK-based drugmaker GlaxoSmithKline PLC is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have

Read more
13 Apr 2014 23:50

GSK faces bribery investigation in Poland -BBC

April 14 (Reuters) - GlaxoSmithKline Plc is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption bet

Read more
11 Apr 2014 15:22

DIRECTOR DEALINGS: GlaxoSmithKline Executive Directors, Managers Acquire Shares

LONDON (Alliance News) - GlaxoSmithKline PLC Friday said that the following executive directors and managers acquired shares at a price of 1585.037 pence per share on Thursday, via a dividend reinvestment.

Read more
10 Apr 2014 15:40

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares

LONDON (Alliance News) - Glaxosmithkline PLC Thursday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1572.79 pence Wednesday.

Details are as follows
<

Read more
10 Apr 2014 11:04

Glaxo, Roche Defend Flu Treatments After Report Calls Them Into Question

LONDON (Alliance News) - GlaxoSmithKline PLC Thursday backed flu treatment Relenza after a report from The Cochrane Collaboration suggested that it and Swiss healthcare company Roche Holdings AG's treatment Tamiflu have little effect. The implications of the report are significant as govern

Read more
10 Apr 2014 10:40

UPDATE 1-Stockpiles of Roche Tamiflu drug are waste of money, review finds

(Updates adding fresh quotes and reaction) By Kate Kelland, Health and Science Correspondent LONDON, April 10 (Reuters) - Researchers who have fought for years to get full data on Roche's flu medicine Tamiflu said on Thursday that governments who stockpile it are wasting billions of d

Read more
10 Apr 2014 05:09

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
9 Apr 2014 23:01

Researchers, regulators and Roche row over stockpiled drug Tamiflu

By Kate Kelland, Health and Science Correspondent LONDON, April 10 (Reuters) - Researchers who have fought for years to get full data on Roche's flu medicine Tamiflu said on Thursday that governments who stockpile it are wasting billions of dollars on a drug whose effectiveness is in doubt.

Read more
9 Apr 2014 15:25

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
9 Apr 2014 05:30

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
8 Apr 2014 15:39

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares as part of a dividend reinvestment of shares held within an ISA at a price of 1583.14 pence per share Friday.

Details are as follows.

<

Read more
8 Apr 2014 15:14

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
7 Apr 2014 16:19

MARKET COMMENT: UK Equities Close In The Red, Tech Stocks Lower

LONDON (Alliance News) - London's major stock indices closed firmly in the red Monday, led lower by technology stocks, following on from an equity sell-off on Wall Street on Friday.

Meanwhile, concerns over a possible further encroachment into Ukraine by Russia also weighed heavily

Read more
7 Apr 2014 11:40

UK MIDDAY BRIEFING: GlaxoSmithKline Investigates Iraq Allegations

LONDON (Alliance News) - Pharmaceuticals giant GlaxoSmithKline has confirmed that is investigating allegations of improper conduct in its Iraq business.

The Wall Street Journal had cited a person familiar with the matter saying that Glaxo was violating US and UK ant

Read more
7 Apr 2014 10:53

GlaxoSmithKline Confirms Investigations Into Iraq Business

LONDON (Alliance News) - GlaxoSmithKline PLC is investigating allegations of improper conduct in its Iraq business, a spokesperson for the company confirmed Monday. "We have zero tolerance for unethical or illegal behaviour," the spokesperson said in a statement. The spokesperson note

Read more

Quickpicks are a member only feature

Login to your account